ArticleKidney international2009
Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.
Article in Kidney international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 21 citations in OpenAlex.
- Tumor induced osteomalacia in head and neck region: single center experience and systematic review.Endocrine connections · 2019Article
- Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.BMC musculoskeletal disorders · 2017Article
- Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level.Clinical kidney journal · 2014Article
- Hypophosphatemic rickets due to perturbations in renal tubular function.Pediatric nephrology (Berlin, Germany) · 2014Review
- Osteomalacia caused by tumors in facies cranii mimicking rheumatoid arthritis.Rheumatology international · 2012Article
- Tumor-induced osteomalacia.Endocrine-related cancer · 2011Review
- Clinical practice. Fibroblast growth factor (FGF)23: a new hormone.European journal of pediatrics · 2011Review
- Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.Pediatric nephrology (Berlin, Germany) · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.